Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Evogene Ltd EVGN

Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to... see more

Recent & Breaking News (NDAQ:EVGN)

Evogene Reports Third Quarter 2023 Financial Results

PR Newswire November 15, 2023

Lavie Bio Reports Advancement in Bio-Fungicide Program Against Downy Mildew with 2023 Field Trial Results

PR Newswire November 8, 2023

Evogene Schedules Third Quarter 2023 Financial Results Release & Conference Call for November 15, 2023

PR Newswire November 2, 2023

Colors Farm, Evogene and Ben-Gurion University Collaborate to Establish Crustacean Gene Editing Technology

PR Newswire October 31, 2023

Evogene Provides Operational Update Amidst Current Security Situation in Israel

PR Newswire October 18, 2023

Casterra Delivers First Shipment of Castor Seeds to Africa

PR Newswire September 27, 2023

Evogene Reports Second Quarter 2023 Financial Results

PR Newswire August 17, 2023

Biomica Opens Second Site to Advance Its Immuno-Oncology Drug Trials at Davidoff Center

PR Newswire August 15, 2023

Evogene Schedules Second Quarter 2023 Financial Results Release & Conference Call for August 17, 2023

PR Newswire August 1, 2023

Evogene's ChemPass AI Tech-Engine is Introduced with New Breakthrough Machine Learning Technology for Target-Protein Discovery

PR Newswire July 25, 2023

Biomica Announces Interim Positive Results from Pre-Clinical Studies in its Irritable Bowel Syndrome (IBS) Program

PR Newswire July 19, 2023

Evogene Announces Pricing of US$8,500,000 Registered Direct Offering

PR Newswire July 17, 2023

Lavie Bio Announces Licensing Agreement for Bio-Fungicides with Corteva Agriscience

PR Newswire July 17, 2023

AgPlenus Appoints Dr. Adrian Percy to Its Board of Directors

PR Newswire July 12, 2023

Casterra Announces Additional $2.2 Million of Purchase Orders to Supply Castor Seeds for New African Territories

PR Newswire July 3, 2023

TalkMarkets Announces Company Spotlight Featuring Evogene

TheNewsWire June 22, 2023

Casterra Signs a Framework Agreement with a World Leading Oil and Gas Company to Sell Its Castor Seeds for Sustainable Biofuel Production, with Initial Purchase Orders of $9.1 Million

PR Newswire June 21, 2023

Lavie Bio Receives Canadian Regulatory Approval for Thrivus(TM), Expanding Global Reach

PR Newswire May 24, 2023

Evogene Schedules First Quarter 2023 Financial Results Release & Conference Call for May 18, 2023

PR Newswire May 4, 2023

Plantis Licenses Two of Canonic's Proprietary Cannabis Varieties to Expand its Offerings in the Israeli Market

PR Newswire May 2, 2023